IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1126-1150 out of 1300.

<< < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 > >>

Public Release: 20-Feb-2014
British Journal of Cancer
Genetic screening can identify men with advanced prostate cancer
Screening men with a family history of prostate cancer for a range of gene mutations can identify those who are at high risk of aggressive forms of the disease and in need of lifelong monitoring, a new study has shown.

Contact: Henry French
henry.french@icr.ac.uk
020-715-35380
Institute of Cancer Research

Public Release: 20-Feb-2014
2014 Multidisciplinary Head and Neck Cancer Symposium
Recurrent mouth and throat cancers less deadly when caused by virus, study shows
People with late-stage cancer at the back of the mouth or throat that recurs after chemotherapy and radiation treatment are twice as likely to be alive two years later if their cancer is caused by the human papillomavirus, new research led by a Johns Hopkins scientist suggests.
NIH/National Cancer Institute, Bristol-Myers Squibb

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

Public Release: 19-Feb-2014
Scientific Reports
Targeted treatment for ovarian cancer discovered
Researchers at Women & Infants Hospital of Rhode Island have developed a biologic drug that would prevent the production of a protein known to allow ovarian cancer cells to grow aggressively while being resistant to chemotherapy. This would improve treatment and survival rates for some women.

Contact: Susan McDonald
slmcdonald@wihri.org
401-681-2816
Women & Infants Hospital

Public Release: 19-Feb-2014
Journal of the National Cancer Institute
HPV vaccination is associated with reduced risk of cervical lesions in Denmark
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published Feb. 19 in the Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
919-677-2697
Oxford University Press

Public Release: 19-Feb-2014
Science Translational Medicine
Cell therapy shows remarkable ability to eradicate cancer in clinical study
The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
NIH/National Cancer Institute, Terry Fox Foundation, and others

Contact: Andrea Baird
bairda@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center

Public Release: 19-Feb-2014
Leukemia
Infants with leukemia inherit susceptibility
Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that may make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.
Children's Discovery Institute, National Institutes of Health, NIH/National Cancer Institute, Alex's Lemonade Stand 'A' Award, Hyundai Hope Award

Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University School of Medicine

Public Release: 19-Feb-2014
New England Journal of Medicine
Adding bevacizumab to initital glioblastoma treatment doesn't improve overall survival
Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group determined that adding bevacizumab to initial treatment for glioblastoma did not improve patient overall survival or progression-free survival. Results appear in the Feb. 20, 2014, issue of the New England Journal of Medicine.

Contact: Nancy Fredericks
nfredericks@acr.org
610-715-7707
American College of Radiology

Public Release: 19-Feb-2014
Biophysical Society 58th Annual Meeting
Clutter cutter
In a messy house, people use computers to manage paper and photo clutter; companies use computer systems to track their inventory. Now a team of researchers at Vanderbilt University in Nashville, Tenn., is taking a similar approach to cell-molecular inventory control for cancer. They have created computer models, using their programming framework, which enable them to explore the complex biochemical processes that drive cancer growth.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 19-Feb-2014
New England Journal of Medicine
Bevacizumab (Avastin) fails to improve survival for newly diagnosed glioblastoma patients
Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
NIH/National Cancer Institute

Contact: Karen Warmkessel
kwarmkessel@umm.edu
410-328-8919
University of Maryland Medical Center

Public Release: 19-Feb-2014
Nature
Gene sequencing project discovers common driver of a childhood brain tumor
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tumor development. The research appears Feb. 19 as an advanced online publication in the scientific journal Nature.
Pediatric Cancer Genome Project, Kay Jewelers, National Institutes of Health, Collaborative Ependymoma Research Network, ALSAC

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 19-Feb-2014
EMBO Reports
Molecular aberration signals cancer
Several scientists, including one at Simon Fraser University, have made a discovery that strongly links a little understood molecule, which is similar to DNA, to cancer and cancer survival. EMBO Reports, a life sciences journal published by the European Molecular Biology Organization, has just published online the scientists' findings about small non-coding RNAs.

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University

Public Release: 19-Feb-2014
Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival or statistically significant progression-free survival for glioblastoma patients in the frontline setting, according to a study led by researchers at the University of Texas MD Anderson Cancer Center.

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center

Public Release: 19-Feb-2014
American Journal of Public Health
LGBT youth face greater cancer risks, CCNY-led study
A new study led by City College of New York psychologist Margaret Rosario found that youths of same-sex orientation are more likely to engage in behaviors associated with cancer risk than heterosexuals. The peer-reviewed findings appear in the February 2014 issue of the American Journal of Public Health.

Contact: Jay Mwamba
jmwamba@ccny.cuny.edu
212-650-7580
City College of New York

Public Release: 18-Feb-2014
Nature Communications
New drug candidate starves dormant cancer cells
In a study published in Nature Communications, researchers at Karolinska Institutet and Uppsala University in Sweden present a new drug candidate, which selectively kills dormant cells within a cancer tumor through starvation.
Swedish Cancer Society, Swedish Research Council

Contact: Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet

Public Release: 18-Feb-2014
British Medical Journal
New anti-smoking policies in China could save nearly 13 million lives in next 40 years
Almost 13 million lives could be saved by 2050 in China if the country implements comprehensive tobacco control recommendations set forth by the World Health Organization.
National Institutes of Health, Fogarty International Center, European Commission, Bloomberg Philanthropy Program

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 18-Feb-2014
eLife
Mitosis mystery solved as role of key protein is confirmed
Researchers from Warwick Medical School have discovered the key role of a protein in shutting down endocytosis during mitosis, answering a question that has evaded scientists for half a century.
Biotechnology and Biological Sciences Research Council

Contact: Luke Harrison
luke.harrison@warwick.ac.uk
University of Warwick

Public Release: 18-Feb-2014
Journal of Clinical Oncology
More women receiving breast reconstruction after mastectomy, study finds
A new study finds that the majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, a practice that has increased dramatically over time.
American Cancer Society, Cancer Prevention and Research Institute of Texas

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 18-Feb-2014
PLOS ONE
Dartmouth-UConn study shows coastal water, not sediment, predicts mercury contamination
A Dartmouth-University of Connecticut study of the northeast United States shows that methylmercury concentrations in estuary waters -- not in sediment as commonly thought -- are the best way to predict mercury contamination in the marine food chain.
NIH/National Institutes of Environmental Health Sciences

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College

Public Release: 18-Feb-2014
PLOS Medicine
The number of tumor cells spread to sentinel lymph nodes affects melanoma prognosis
Cancer cell spread to the sentinel node -- the lymph node to which cancer cells are most likely to spread from a primary tumor -- is a risk factor for melanoma death.
University of Tübingen

Contact: Fiona Godwin
medicinepress@plos.org
PLOS

Public Release: 18-Feb-2014
The Lancet
Cancer study shows earlier palliative care improves quality of life, patient satisfaction
Results of the first clinical study to assess the impact of providing early outpatient palliative care versus standard oncology care in a wide range of advanced cancers show that earlier care improved quality of life and patient satisfaction.

Contact: Jane Finlayson
jane.finlayson@uhn.ca
416-946-2846
University Health Network

Public Release: 18-Feb-2014
Nucleic Acids Research
Wistar scientists develop gene test to accurately classify brain tumors
Scientists at the Wistar Institute have developed a mathematical method for classifying forms of glioblastoma, an aggressive and deadly type of brain cancer, through variations in the way these tumor cells 'read' genes. Their system was capable of predicting the subclasses of glioblastoma tumors with 92 percent accuracy. With further testing, this system could enable physicians to accurately predict which forms of therapy would benefit their patients the most.
National Institutes of Health

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute

Public Release: 18-Feb-2014
Nature Biotechnology
Research team establishes benchmark set of human genotypes for sequencing
Scientistis from Harvard University and the Virginia Bioinformatics Institute of Virginia Tech have presented new methods to integrate data from different sequencing platforms, thus producing a reliable set of genotypes to benchmark human genome sequencing.

Contact: Tiffany Trent
ttrent@vt.edu
540-231-6822
Virginia Tech

Public Release: 18-Feb-2014
PLOS ONE
COXEN model picks the best drug for ovarian cancer
A University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 18-Feb-2014
Evolutionary Applications
Infected Tasmanian devils reveal how cancer cells evolve in response to humans
New research in Evolutionary Applications explains how efforts to tackle Tasmanian devil tumors offers a unique opportunity to understand how human selection alters the evolution of cancerous cells.

Contact: Ben Norman
Sciencenewsroom@wiley.com
44-012-437-70375
Wiley

Public Release: 18-Feb-2014
Proceedings of the National Academy of Sciences
New treatment proposed to prevent intestinal inflammation in cancer patients
Experimental work pointing to a therapy for alleviating mucositis -- a common, severe side effect of chemotherapy and irradiation of cancer patients or patients prepared for bone marrow transplantation -- has been achieved by an international team of researchers from the US and Israel headed by scientists at the Hebrew University of Jerusalem.

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem

Showing releases 1126-1150 out of 1300.

<< < 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 > >>

  Search News Releases

     

 

 

EurekAlert!